Form 4: Immuneering CFO Receives Stock Grant
Insider Transaction (Form 4)
Andrew Gengos, Chief Financial Officer of Immuneering Corp, received 650,000 shares of common stock on July 16, 2026.
Summary
- Grant/award: acquired 650,000 Stock Option on July 16, 2026; holds 650,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew Gengos — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Stock Option | 650,000 | — | — | 650,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (650,000 shares) |
Keywords
insider transaction, Form 4, IMRX, Immuneering Corp, neutral, Andrew Gengos
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.